3/20
12:31 pm
lumo
Lumos Pharma, Inc. (NASDAQ: LUMO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
Medium
Report
Lumos Pharma, Inc. (NASDAQ: LUMO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
3/20
12:26 pm
lumo
Rating for LUMO
Medium
Report
Rating for LUMO
3/20
12:26 pm
lumo
Rating for LUMO
Medium
Report
Rating for LUMO
3/8
09:03 am
lumo
Rating for LUMO
Low
Report
Rating for LUMO
3/8
09:03 am
lumo
Rating for LUMO
Low
Report
Rating for LUMO